Difficulty: Medium
Average Score: 87%
Practice
Which of the following conditions most likely delayed the oral absorption of acetaminophen in the patient with the excruciating headache?
Correct answer
B
Rationale
In this scenario, the correct answer is B) The presence of strong pain. When a patient is experiencing strong pain, especially an excruciating headache, it can lead to decreased gastrointestinal motility due to the activation of the sympathetic nervous system in response to pain. This decreased motility can delay the absorption of orally administered medications like acetaminophen.
Option A, a moderate increase in intestinal peristalsis, would actually promote faster absorption of acetaminophen rather than delay it. Option C, the administration of the drug in aqueous solution, would not significantly impact the absorption rate of acetaminophen. Option D, a large volume of distribution of the drug, pertains more to the distribution phase rather than the absorption phase of pharmacokinetics.
In an educational context, understanding how different physiological conditions can affect drug absorption is crucial for healthcare professionals to make informed decisions about drug dosing and timing, especially in patients with specific conditions like pain that can influence drug pharmacokinetics. This knowledge helps optimize therapeutic outcomes and avoid potential treatment failures.
Option A, a moderate increase in intestinal peristalsis, would actually promote faster absorption of acetaminophen rather than delay it. Option C, the administration of the drug in aqueous solution, would not significantly impact the absorption rate of acetaminophen. Option D, a large volume of distribution of the drug, pertains more to the distribution phase rather than the absorption phase of pharmacokinetics.
In an educational context, understanding how different physiological conditions can affect drug absorption is crucial for healthcare professionals to make informed decisions about drug dosing and timing, especially in patients with specific conditions like pain that can influence drug pharmacokinetics. This knowledge helps optimize therapeutic outcomes and avoid potential treatment failures.